Marketable Securities, Current of PharmaCyte Biotech, Inc. from 30 Apr 2024 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: PharmaCyte Biotech, Inc. quarterly Marketable Securities, Current in USD history and change rate from 30 Apr 2024 to 31 Oct 2025.
PharmaCyte Biotech, Inc. Marketable Securities, Current for the quarter ending 31 Oct 2025 was $201,190.
Source SEC data: View on sec.gov

Marketable Securities, Current, Quarterly (USD)

PharmaCyte Biotech, Inc. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$201,190			31 Oct 2025	10-Q	18 Dec 2025	2026	Q2
Q2 2025	$261,853			31 Jul 2025	10-Q	15 Sep 2025	2026	Q1
Q1 2025	$366,316	+$366,316		30 Apr 2025	10-Q	18 Dec 2025	2026	Q2
Q4 2024	$372,632			31 Jan 2025	10-Q	17 Mar 2025	2025	Q3
Q1 2024	$0			30 Apr 2024	10-K	11 Aug 2025	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.